CRP testing aids coronavirus management in China
Although there are very limited available research data, currently spreading novel coronavirus (2019-nCoV) seems to increase C-reactive protein (CRP) levels significantly, due to viral alveolar damage that was also seen in the SARS epidemic in 2002. General Office of the Chinese National Health Commission has released a guideline to guide the diagnosis and treatment of 2019-nCoV recommending the use of CRP tests together with other clinical parameters for evaluation and follow-up of coronavirus infection.
Aidian participates in the fight against the coronavirus outbreak by providing cost-efficient CRP test solutions for the management of infection in China. QuikRead go CRP point-of-care tests provide fast and reliable test results that can be immediately used for making decisions about the patient’s management.